Crinetics Pharmaceuticals, Inc.
Total Trades
109
Buys
2
Sells
77
Largest Trade
N/A
Insiders
14
Institutional Funds
195
Inst. Value
$1M+
Activist Filings
41
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Fust Matthew K | Director | EXERCISE | $1M+ | 60K | $20.92 | Mar 22, 2024 |
| Fust Matthew K | Director | SELL | $1M+ | 60K | $44.14 | Mar 22, 2024 |
| Wilson Marc | CFO | SELL | $100K–$500K | 7K | $42.91 | Mar 20, 2024 |
| Betz Stephen F. | Chief Scientific O… | SELL | $100K–$500K | 3K | $37.26 | Jan 26, 2024 |
| Pizzuti Dana | Chief Med and Dev … | SELL | $500K+ | 14K | $35.00 | Jan 4, 2024 |
| Pizzuti Dana | Chief Med and Dev … | EXERCISE | $100K–$500K | 14K | $16.89 | Jan 4, 2024 |
| Wilson Marc | CFO | EXERCISE | $50K–$100K | 10K | $9.28 | Jan 4, 2024 |
| Wilson Marc | CFO | SELL | $100K–$500K | 10K | $35.47 | Jan 4, 2024 |
| Betz Stephen F. | Chief Scientific O… | SELL | $100K–$500K | 3K | $35.89 | Dec 27, 2023 |
| Pizzuti Dana | Chief Med and Dev … | SELL | $100K–$500K | 10K | $34.57 | Dec 22, 2023 |
| Pizzuti Dana | Chief Med and Dev … | EXERCISE | $100K–$500K | 10K | $16.89 | Dec 22, 2023 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 3K | $31.84 | Nov 29, 2023 |
| Struthers Richard Scott | President & CEO | SELL | $1M+ | 200K | $30.56 | Nov 6, 2023 |
| Struthers Richard Scott | President & CEO | EXERCISE | $1M+ | 200K | $9.28 | Nov 6, 2023 |
| Wilson Marc | CFO | SELL | $100K–$500K | 10K | $28.75 | Nov 3, 2023 |
| Wilson Marc | CFO | EXERCISE | $50K–$100K | 10K | $9.28 | Nov 3, 2023 |
| Krasner Alan Seth | Chief Medical Offi… | SELL | $100K–$500K | 7K | $30.00 | Oct 19, 2023 |
| Krasner Alan Seth | Chief Medical Offi… | EXERCISE | $50K–$100K | 7K | $12.01 | Oct 19, 2023 |
| Struthers Richard Scott | President & CEO | SELL | $1M+ | 50K | $20.21 | Jul 13, 2023 |
| Wilson Marc | CFO | SELL | $500K+ | 31K | $19.97 | Jun 21, 2023 |
| Wilson Marc | CFO | EXERCISE | $100K–$500K | 20K | $9.28 | Jun 21, 2023 |
| Struthers Richard Scott | President & CEO | SELL | $1M+ | 50K | $20.81 | Jun 21, 2023 |
| Vivaldi Coelho Rogerio | Director | BUY | $100K–$500K | 5K | $22.06 | Jun 9, 2023 |
| Pizzuti Dana | Chief Development … | SELL | $100K–$500K | 8K | $16.15 | Apr 5, 2023 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 3K | $19.59 | Feb 3, 2023 |
| Betz Stephen F. | Chief Scientific O… | SELL | $100K–$500K | 8K | $21.07 | Jan 27, 2023 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 3K | $18.00 | Jan 19, 2023 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 3K | $18.35 | Jan 5, 2023 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 3K | $16.00 | Dec 19, 2022 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 3K | $17.84 | Dec 5, 2022 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 3K | $18.72 | Nov 17, 2022 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 3K | $18.52 | Nov 3, 2022 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 3K | $17.73 | Oct 19, 2022 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 3K | $19.64 | Oct 5, 2022 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 4K | $21.01 | Sep 19, 2022 |
| Betz Stephen F. | Chief Scientific O… | SELL | $15K–$50K | 1K | $21.00 | Sep 9, 2022 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 3K | $18.59 | Sep 6, 2022 |
| Knight Jeff E. | COO | SELL | $15K–$50K | 1K | $20.70 | Jul 29, 2022 |
| Fust Matthew K | Director | SELL | $100K–$500K | 6K | $20.96 | Jul 15, 2022 |
| Fust Matthew K | Director | EXERCISE | $1K–$15K | 6K | $1.45 | Jul 15, 2022 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 3K | $20.10 | May 4, 2022 |
| Betz Stephen F. | Chief Scientific O… | SELL | $100K–$500K | 6K | $25.81 | Apr 21, 2022 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | BUY | $1M+ | 158K | $22.22 | Apr 18, 2022 |
| Struthers Richard Scott | President & CEO | SELL | $1M+ | 139K | $26.83 | Apr 15, 2022 |
| Struthers Richard Scott | President & CEO | SELL | $500K+ | 21K | $25.34 | Apr 7, 2022 |
| Betz Stephen F. | Chief Scientific O… | SELL | $100K–$500K | 9K | $23.97 | Apr 6, 2022 |
| Betz Stephen F. | Chief Scientific O… | SELL | $100K–$500K | 8K | $21.43 | Apr 1, 2022 |
| Betz Stephen F. | Chief Scientific O… | SELL | $50K–$100K | 3K | $18.94 | Mar 17, 2022 |
| Madan Ajay | Chief Development … | GRANT | N/A | 14K | — | Mar 3, 2022 |
| Madan Ajay | Chief Development … | SELL | $100K–$500K | 9K | $19.88 | Mar 3, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 195 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Point72 Asset Management, L.P. | 2.3M | $1M+ | SH |
| STATE STREET CORP | 2.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9M | $1M+ | SH |
| Novo Holdings A/S | 1.6M | $1M+ | SH |
| Pictet Asset Management Holding SA | 1.6M | $1M+ | SH |
| Siren, L.L.C. | 1.5M | $1M+ | SH |
| GW&K Investment Management, LLC | 1.4M | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 1.2M | $1M+ | SH |
| First Light Asset Management, LLC | 1.2M | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 1.1M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 999K | $1M+ | SH |
| Candriam S.C.A. | 831K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 782K | $1M+ | SH |
| Fisher Asset Management, LLC | 759K | $1M+ | SH |
| Aberdeen Group plc | 675K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 518K | $1M+ | SH |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 408K | $1M+ | SH |
| Ikarian Capital, LLC | 369K | $1M+ | SH (Put) |
| ADAR1 Capital Management, LLC | 309K | $1M+ | SH |
| ADAR1 Capital Management, LLC | 309K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 5, 2026
0.6%
585K shares
Wellington Management Group LLP
SC 13G/A · Nov 12, 2025
8.9%
8.4M shares
Farallon Capital Partners, L.P.
SC 13G · Sep 8, 2025
0.4%
398K shares
Wellington Management Group LLP
SC 13G/A · Aug 12, 2025
6.2%
5.8M shares
SC 13G/A · May 12, 2025
15.0%
14.0M shares
SC 13G/A · Apr 7, 2025
10.0%
9.3M shares
Wellington Management Group LLP
SC 13G/A · Feb 10, 2025
7.5%
7.0M shares
SC 13G/A · Feb 7, 2025
10.4%
9.6M shares
SC 13G/A · Feb 7, 2025
9.6%
8.9M shares
SC 13G/A · Jan 31, 2025
9.8%
9.1M shares
Point72 Asset Management, L.P.
SC 13G/A · Nov 15, 2024
2.9%
2.3M shares
SC 13G/A · Nov 14, 2024
4.8%
4.3M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Nov 14, 2024
6.2%
4.9M shares
SC 13G/A · Nov 12, 2024
7.8%
6.3M shares
Wellington Management Group LLP
SC 13G · Nov 8, 2024
5.6%
4.5M shares
SC 13G/A · Nov 4, 2024
7.8%
6.3M shares
STATE STREET CORPORATION 04-2456637
SC 13G/A · Oct 17, 2024
3.6%
2.8M shares
SC 13G · Mar 11, 2024
5.3%
4.2M shares
SC 13D/A · Mar 2, 2024
148.9M shares
SC 13G/A · Feb 14, 2024
2.5%
1.7M shares
Point72 Asset Management, L.P.
SC 13G/A · Feb 14, 2024
5.1%
3.4M shares
SC 13G/A · Feb 14, 2024
0.0%
0 shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2024
0.0%
0 shares
DRIEHAUS CAPITAL MANAGEMENT LLC
SC 13G/A · Feb 14, 2024
7.5%
5.0M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.2%
3.5M shares
SC 13G/A · Jan 25, 2024
8.0%
5.3M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Jan 24, 2024
5.3%
0 shares
Point72 Asset Management, L.P.
SC 13G · Sep 18, 2023
5.6%
3.7M shares
SC 13G/A · Feb 14, 2023
5.0%
2.7M shares
SC 13G · Feb 14, 2023
6.5%
3.5M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2023
2.7%
1.4M shares
SC 13G/A · Jan 31, 2023
7.3%
3.9M shares
SC 13D/A · Apr 25, 2022
10.0%
5.3M shares
SC 13D/A · Apr 21, 2022
10.0%
5.3M shares
SC 13G/A · Feb 14, 2022
4.0%
1.9M shares
SC 13G/A · Feb 11, 2022
0.0%
0 shares
SC 13G/A · Feb 11, 2022
5.7%
2.7M shares
Versant Venture Capital V, L.P.
SC 13G/A · Feb 11, 2022
0.8%
360K shares
SC 13G/A · Feb 10, 2022
4.2%
2.0M shares
SC 13G/A · Jan 10, 2022
7.8%
3.7M shares
DRIEHAUS CAPITAL MANAGEMENT LLC
SC 13G · Jan 10, 2022
10.1%
4.8M shares